Amid reports of "faulty" hip replacements surgeries by multinational company Johnson and Johnson, the Union Health Ministry has decided to form committees at the state levels so that they can receive such complaints from affected patients.
The move comes after reports appeared in the media, saying the pharma giant "suppressed" facts on the harm of surgeries afterwards which was conducted on patients in India using "faulty" hip replacement systems.
According to reports, the expert committee, set up to investigate complaints about hip implant devices also has suggested that the company pay compensation of around Rs 20 lakh to the affected patients.
The Health Ministry said following the reports which appeared in the media, it has directed the formation of state level committees for hearing the grievances.
"The compensation to the patients will be decided based on examinations done on them. Now we have to assess how many (patients) are affected due to it. That is why state committees will be formed.
"Apart from this, advertisements will also be put up in prominent newspapers so that the affected patients know about this and can approach the committee with their grievances,"," The drugs controller general of India Eswara Reddy told PTI.
Sources in the Ministry said that once the state committees examines those affected, then they will give their recommendations to the expert committee at the Centre and accordingly the company will asked to compensate.
Reports quoting the expert committee findings say that over 3,600 patients with the faulty implants remain untraceable, and that at least four deaths have been reported from those who underwent surgeries using these devices.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
